ADAPALENE 0.1%w/w IP + SODIUM METHYLPARABEN 0.1%w/w IP + SODIUM PROPYL PARABEN 0...

A synthetic retinoid analog for the topical treatment of acne vulgaris. (John Waugh, 2004) A third-generation retinoid with proven effectiveness in the treatment of acne vulgaris. (Aura Rusu, 2020) Possesses comedolytic, anti-inflammatory, antiproliferative, and immunomodulatory properties. (Aura Rusu, 2020) Provides superior efficacy and better tolerability than tretinoin 0.025% gel in the treatment of acne vulgaris A good alternative for the treatment of mild to moderate acne vulgaris patients than tretinoin 0.025% gel. (P Tu, 2001) Reduces inflammatory and total lesion counts more rapidly than tretinoin 0.025% gel. (E Grosshans, 1998) A potent retinoid with anti-inflammatory properties and treats by regulating cellular differentiation and stabilizing abnormal desquamation. (Diane Berson, 2013) A safe and effective candidate in treating acne vulgaris, reducing inflammatory and noninflammatory lesions. (Diane Berson, 2013) A better-tolerated agent than several tretinoin formulations as well as tazarotene. (Diane Berson, 2013) Offers a rapid onset of action and a favorable tolerability profile compared with other retinoids. (John Waugh, 2004) An effective and better-tolerated alternative to tretinoin 0.025% gel for the topical treatment of patients with mild to moderate acne. (R N Brogden, 1997) A valuable addition to current treatments for acne vulgaris. (Millikan, 2001) Significantly better tolerated than tazarotene 0.1% gel, tretinoin 0.025% and tretinoin 0.05% gel, tretinoin 0.05% cream, tretinoin microsphere 0.1% gel or isotretinoin 0.05% gel in mild to moderate acne patients. (Anja Thielitz, 2008)